Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Capital/Financing Update 2009

Jan 6, 2009

65122_rns_2009-01-06_cecb884f-acff-4489-b14b-3363d75d5752.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [193 x 52] intentionally omitted <==

ASX Release Stock Code: PRR

Wednesday, 7[Th] January 2009

COMPLETION OF SHARE PURCHASE PLAN

The Directors of Prima Biomed Limited (ASX: PRR) wish to advise that the Company’s Share Purchase Plan has closed with applications received totalling $198,000 representing 39,600,000 ordinary shares.

For further information please contact:

Mr Martin Rogers Executive Director Prima BioMed Ph: 02 9232 4420 Email: [email protected]

Prima BioMed Ltd , Suite 1705, 109 Pitt Street, Sydney, NSW Australia 2000 Ph: +61 (0)2 9232 4420 Fax: + 61 (0)2 9232 4450 www.primabiomed.com.au ABN 90 009 237 889